Latest return on equity
Nektar Therapeutics Return on equity
Direct answer
Nektar Therapeutics's return on equity is -35.76%.
The verified market snapshot reports -35.76%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 5, 2026.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -35.76%
Explore related company data
View Nektar Therapeutics's market capitalizationView Nektar Therapeutics's price-to-book ratioView Nektar Therapeutics's 52-week price rangeView Nektar Therapeutics's revenue growthView Nektar Therapeutics's profit marginView Nektar Therapeutics's debt-to-equity ratioView all Nektar Therapeutics key metricsReturn to Nektar Therapeutics profile